![]() |
市場調查報告書
商品編碼
1627797
全球非基因改造大豆市場:預測(2025-2030)Global Non-GMO Soybean Market - Forecasts from 2025 to 2030 |
全球非基因改造 (GMO) 大豆市場預計在預測期內將以 3.74% 的年複合成長率(CAGR)成長。
有幾個關鍵因素正在推動非基因改造大豆市場的成長。第一個促進因素是消費者對基改作物潛在健康風險的擔憂增加。對過敏性、抗生素抗藥性以及對人類健康的廣泛影響的擔憂導致許多人積極尋求非基因改造替代品,例如非基因改造大豆。
此外,非基因改造大豆的生產通常與更永續的農業實踐相關,例如減少農藥和除草劑的使用以及促進生物多樣性。此外,一些國家也限制或徹底禁止使用基因改造產品,為非基因改造大豆生產商創造了利潤豐厚的出口機會,並擴大了全球市場。
特別是美國是最大的大豆出口國之一,2023年產量為49噸。美國農業部估計,美國約有 440 萬英畝土地專門用於種植非基因改造大豆,到 2022 年,87,455,000 英畝大豆總面積中的 1,924,010 英畝將分配給非基因大豆種植。
此外,人們對基因改造標籤法規的認知不斷提高,一些國家對基因改造產品實施強制標籤。這種透明度的提高可以使消費者做出明智的選擇,並導致對大豆等非基因改造食品的需求增加。
非基因改造大豆市場的促進因素
越來越多的消費者開始採用素食、純素和彈性素食飲食,推動對植物蛋白替代品的需求大幅成長。非基因改造大豆以其多功能性和成本效益而聞名,使其成為許多植物性肉類替代品、乳製品替代品和各種其他食品的關鍵成分。
根據歐盟委員會最近發布的報告,歐盟27國大豆種植面積預計將擴大30%,從2023年的100萬公頃達到2035年的130萬公頃。
報告預測,2023 年至 2035 年間,歐盟境內的土地用途將發生重大轉變,從種植穀物轉向種植大豆和豆類。這些土地利用變化是由於對作為飼料的穀物的需求下降、促進輪作和蛋白質作物種植的政策獎勵、對植物蛋白和當地產品的需求增加、非基因改造標籤產品的激增,這這是由多種因素推動的,包括轉向不毀林的大豆生產。
此外,消費者越來越重視消費動物性蛋白質對健康的影響以及畜牧業對環境的影響。與傳統的動物性蛋白質來源相比,非基因改造大豆被認為是更健康、更永續的替代蛋白質來源。
非基因改造大豆市場的地理展望
從區域來看,市場分為北美、南美、歐洲、中東/非洲和亞太地區。由於商品大豆價格低廉、溢價誘人以及基改大豆種子成本上升,美國農民正在增加非基改大豆的種植面積。大學代表、糧食買家和大豆協會代表均表示,隨著非基因改造大豆需求的增加,非基因改造大豆的種植面積將會增加。自採用以來,基改抗農達大豆已占美國大豆種植面積的大部分。
在美國,2021年種植的8,720萬英畝大豆中,有440萬英畝將種植非基因改造作物。相較之下,2022 年和 2020 年預計面積分別為 410 萬英畝和 500 萬英畝。美國大豆種植者種植了約 260 萬英畝食品級大豆,這些大豆被出售用於豆腐、豆奶、味噌、納豆和豆芽等用途。剩餘的170萬英畝土地被用作飼料大豆。
此外,國際企業的進入預計將進一步提振國內非基因改造大豆需求。例如,2024 年 1 月,密蘇裡州大豆商品行銷委員會和以其優質機會和遺傳多樣性而聞名的 Beck's 宣布了一項 SOYLEIC® 大豆的戰略授權合約。透過利用 Beck 的廣泛網路,這項合作關係將使高油酸 (HO) 產業受益,並完美補充 SOYLEIC® 為大豆農民提供 HO 基因的目標。
與傳統油相比,高油酸大豆油具有許多優點和一些理想的特性。來自美國的高油酸大豆油可改善脂肪分佈,增加中性風味,延長產品保存期限,讓您的食物成為焦點。它還提供所有食用油中最長的煎炸時間。此外,SOYLEIC(R) 是目前市面上其他高油酸大豆品種中唯一的非基因改造大豆品種。
此外,2022 年 2 月,解鎖植物遺傳多樣性的食品科技公司 Benson Hill, Inc. 宣布推出具有特殊永續性優勢的國產非基因改造植物蛋白成分新系列 TruVailTM。 TruVailTM 品牌提供的首批產品是高蛋白大豆粉、大豆濃縮蛋白 (SPC) 的低加工版本,以及可用於傳統大豆蛋白以及快速大豆蛋白的多種應用的組織化蛋白。替代植物性蛋白質市場。
為什麼要購買這份報告?
它有什麼用?
產業和市場考量、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範與影響、新產品開發、競爭影響。
The global non-genetically modified organisms (GMO) soybean market is anticipated to grow at a compound annual growth rate (CAGR) of 3.74% over the forecast period.
Several significant factors are driving the global non-GMO soybean market growth. A primary driver is the increasing consumer concern regarding the potential health risks associated with GMOs. Worries about allergenicity, antibiotic resistance, and broader implications on human health are prompting many individuals to actively seek out non-GMO alternatives, such as non-GMO soybeans.
Additionally, non-GMO soybean production is often associated with more sustainable farming practices, including reduced pesticide and herbicide usage, as well as the promotion of biodiversity. Furthermore, some countries have implemented restrictions or outright bans on GMO products, creating lucrative export opportunities for non-GMO soybean producers and thereby expanding the global market.
Notably, the United States stands as one of the largest exporters of soybeans, with a production of 49 metric tons in 2023. The USDA estimates that approximately 4.4 million acres in the U.S. are dedicated to non-GMO soybean cultivation, and 1,924,010 will be given to non-GMO food-grade soybeans out of a total soybean acreage of 87,455,000 in 2022.
Moreover, there is a growing awareness surrounding GMO labeling regulations, with some countries mandating labeling requirements for GMO products. This increased transparency empowers consumers to make informed choices and can lead to heightened demand for non-GMO options like soybeans.
Global non-GMO soybean market drivers
A growing number of consumers are embracing vegetarian, vegan, or flexitarian diets, which has spurred a significant uptick in the demand for plant-based protein alternatives. Non-GMO soybeans, renowned for their versatility and cost-effectiveness, serve as a pivotal ingredient in numerous plant-based meat substitutes, dairy alternatives, and various other food products.
According to a recent report published by the European Commission, it is projected that the soybean cultivation area within the EU-27 will witness a 30% expansion, reaching 1.3 million hectares by 2035, up from 1.0 million hectares in 2023.
The report anticipates a notable shift in land utilization within the EU, with a transition from cereals to soybeans and pulses between 2023 and 2035. This shift in land use is driven by several factors, including anticipated reduced demand for cereals as feed, policy incentives promoting crop rotation and the cultivation of protein crops, escalating demand for plant-based proteins and local products, a surge in GMO-free labeled products, and a push towards deforestation-free soybean production.
Further, consumers are increasingly prioritizing concerns regarding the health implications of animal protein consumption and the environmental footprint of animal agriculture. Non-GMO soybeans are perceived as a healthier and more sustainable alternative protein source compared to traditional animal-derived protein sources.
Global non-GMO soybean market geographical outlook
Based on geography, the global baby body care market is segmented into North America, South America, Europe, the Middle East and Africa, and the Asia Pacific. American farmers are planting more non-GMO soybeans due to low commodity soybean prices, attractive premiums, and rising costs for genetically modified soybean seed. University representatives, grain buyers, and soybean association representatives all state that as demand for non-GMO soybeans rises, more non-GMO acres will be planted. Since their introduction, genetically modified Roundup Ready soybeans have accounted for a growing portion of US soybean acreage annually.
In the United States, 4.4 million of the 87.2 million soybean acres planted in 2021 are non-GMO. This is contrasted with an estimated 4.1 million in 2022 and 5 million in 2020. About 2.6 million acres were planted by American soy farmers with food-grade soybeans, which are sold for tofu, soymilk, miso, natto, sprouts, and other uses. Feed-grade soy covered the remaining 1.7 million acres of non-GMO soy.
In addition, expansion ventures by international players into the market are further expected to boost the non-GMO soybeans demand in the country. For instance, in January 2024, the Missouri Soybean Merchandising Council and Beck's, renowned for their premium opportunities and diverse genetics, announced a strategic licensing agreement with SOYLEIC(R) soybeans. By utilizing Beck's extensive network, this partnership benefits the high oleic (HO) sector and perfectly complements SOYLEIC(R)'s objective of providing soybean farmers with access to HO genetics.
In contrast to conventional oils, high oleic soybean oil offers numerous advantages and several desirable characteristics. American-grown high-oleic soybean oil improves the fat profile, adds a neutral flavor, prolongs the shelf life of products, and lets the food take center stage. It also offers some of the longest fry times of any edible oil. Furthermore, SOYLEIC(R) is the only non-GMO soybean variety currently offered, even though there are other high oleic varieties on the market.
Moreover, in February 2022, TruVailTM, a new line of domestically sourced, non-GMO plant-based protein ingredients with special sustainability benefits, was introduced by Benson Hill, Inc., a food technology company that is unlocking the genetic diversity of plants. The first products offered by the TruVailTM brand are high-protein soy flour, a less processed version of soy protein concentrate (SPC), and texturized proteins that can be used in a variety of conventional soy protein applications as well as the quickly expanding markets for alternative plant-based proteins.
Reasons for buying this report:-
What do businesses use our reports for?
Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence